As we know, timely access to affordable and appropriate medications can significantly improve health outcomes and enhance quality of life. By expanding treatment options and promoting competition, generic and biosimilar medicines can improve access, sustainability of healthcare systems, and alleviate the societal burden of untreated illnesses.

Patient organisations provide a powerful voice for patients and can help policymakers understand the perspectives of the patient community as they work to implement better health policies. Many of our members play a vital role in enhancing access to medicines, educating their communities and empowering patients to make informed decisions.

Recently, ASIF participated alongside 30 patient advocacy leaders from 18 countries, in the Making Access Happen: Sandoz Global Access Forum.